BSX - BOSTON SCIENTIFIC CORP
This page shows which of the focused investors we track hold BSX and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2025 it was held by 7 managers with an aggregate reported value of $1.45B, which is 0.12% of the combined portfolio.
As of Q4 2025, 7 tracked institutional managers held BSX (BOSTON SCIENTIFIC CORP) with an aggregate reported value of $1.45B — 0.12% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BSX — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2025
- Ticker
- BSX
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | John Armitage - Egerton Capital | 5.58% | Add +1.4% | 5,385,084 | $513.47M |
| 2 | Polen Capital Management - Polen Capital Management | 1.64% | Reduce -28.2% | 4,019,552 | $383.26M |
| 3 | Lee Ainslie - Maverick Capital | 3.02% | New | 2,944,254 | $280.73M |
| 4 | Viking Global Investors - Viking Global Investors | 0.64% | Reduce -5.0% | 2,509,808 | $239.31M |
| 5 | Stephen Mandel - Lone Pine Capital | 0.14% | New | 201,703 | $19.23M |
| 6 | Dodge & Cox - Dodge & Cox | 0.00% | - | 88,885 | $8.48M |
| 7 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.01% | Reduce -1.3% | 10,176 | $970.28K |
Loading holder history for BSX…